PlainPharmaWatch

CMS Open Payments · Tool

Cardiva Medical, Inc. vs OPKO Pharmaceuticals, LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Cardiva Medical, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 833, versus 350 for the other company. Its single largest recorded recipient represents 0.3% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Cardiva Medical, Inc.
HHI 833 · top recipient 0.3%
Ranked #1,101 of 1,838 companies by HHI
OPKO Pharmaceuticals, LLC
HHI 350 · top recipient 0.1%
Ranked #1,420 of 1,838 companies by HHI

Payment Overview

Total Payments
$741.8K
% of Industry
0.0%
Transactions
7,311
Avg per Transaction
$101.46
Recipients
7,304
Avg per Recipient
$101.56
Payment Types
7
Top Payment Type
Consulting Fee
Total Payments
$740.7K
% of Industry
0.0%
Transactions
6,610
Avg per Transaction
$112.06
Recipients
6,592
Avg per Recipient
$112.37
Payment Types
6
Top Payment Type
Compensation for Services Other Than Consulting

Highlighted values indicate the higher figure for each metric.

Total payments compared

Cardiva Medical, Inc. vs OPKO Pharmaceuticals, LLC - total reported payments in CMS Open Payments PY2024

Cardiva Medical, Inc.$741.8KOPKO Pharmaceuticals, LLC$740.7K

Payment Types Breakdown

Cardiva Medical, Inc.

Consulting Fee $383.9K

51.8%

Food and Beverage $208.1K

28.1%

Space Rental or Facility Fees $45.7K

6.2%

Grant $45.0K

6.1%

Education $30.0K

4.0%

Travel and Lodging $1.4K

0.2%

OPKO Pharmaceuticals, LLC

Compensation for Services Other Than Consulting $99.9K

13.5%

Food and Beverage $73.7K

9.9%

Education $42.1K

5.7%

Honoraria $11.9K

1.6%

Consulting Fee $8.0K

1.1%

Travel and Lodging $158.05

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Cardiva Medical, Inc.

  1. 1

    PHILIPPE GENEREUX

    $193,610.57 · 36 txns

  2. 2

    WASHINGTON HOSPITAL CENTER

    $35,000.00 · 4 txns

  3. 3

    RAMIN S HASTINGS

    $24,409.21 · 15 txns

  4. 4

    NOURI AL KHALED

    $24,124.71 · 10 txns

  5. 5

    HUGH MCELDERRY

    $21,760.51 · 3 txns

OPKO Pharmaceuticals, LLC

  1. 1

    VARSHASB BROUMAND

    $24,893.42 · 54 txns

  2. 2

    RONALD LEVY

    $20,000.00 · 2 txns

  3. 3

    JOHN HEYMACH

    $20,000.00 · 2 txns

  4. 4

    ERIC RUBIN

    $14,600.00 · 7 txns

  5. 5

    HARRY DOUNIS

    $10,593.34 · 17 txns

Summary Comparison

Metric Cardiva Medical, Inc. OPKO Pharmaceuticals, LLC
Total Payments $741.8K $740.7K
% of Industry Total 0.0% 0.0%
Transaction Count 7,311 6,610
Avg per Transaction $101.46 $112.06
Recipient Count 7,304 6,592
Avg per Recipient $101.56 $112.37
Payment Type Count 7 6
Top Payment Type Consulting Fee Compensation for Services Other Than Consulting

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.